BAUSCH HEALTH COMPAN

BHC
Delayed Quote. Delayed  - 04/09 04:10:00 pm
30.78USD +0.03%

Turn to zoom
Prev.30.7700
Open30.9200
High31.0850
Low30.5300
Volume2 060 770
Latest news
1d ago
2d ago
3d ago
3d ago
Chart BAUSCH HEALTH COMPANIES INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance32,834,433,3
Spread/Res.-6,2%-10%-7,7%
Spread/Supp.0,29%24%35%
Support30,724,822,9
Financials
Sales 2021 8 706 M - -
Net income 2021 -34,8 M - -
Net Debt 2021 21 715 M - -
P/E ratio 2021 -700x
Yield 2021 -
Capitalization 10 947 M 10 947 M -
EV / Sales 2021 3,75x
EV / Sales 2022 3,45x
Nbr of Employees 21 600
Free-Float 97,8%
Company
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-04-27 Shareholder meeting
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 34,65 $
Last Close Price 30,78 $
Spread / Highest target 78,7%
Spread / Average Target 12,6%
Spread / Lowest Target -35,0%